Beck Bode LLC’s Alkermes ALKS Stock Holding History

Beck Bode LLC’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-27,272	Closed	-$738K	–	107
2024 Q1	$738K	Buy	+27,272	New	+$775K	0.15%	95

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's ALKS Position: Q2 2024 in Review

Beck Bode LLC sold out of Alkermes (ALKS) in Q2 2024, closing a stake of 27,272 shares — an estimated $738K sold.

Beck Bode LLC first reported a position in ALKS in Q1 2024 and held it in 1 quarter. The position peaked at $738K in Q1 2024. 322 funds tracked by Wall St. Rank hold ALKS as of Q2 2024.

Beck Bode LLC reported no remaining Alkermes position as of Q2 2024 after selling out during the quarter.
Beck Bode LLC sold 27,272 Alkermes shares in Q2 2024, an estimated $738K.
Beck Bode LLC first reported a position in Alkermes in Q1 2024 and held it in 1 quarter.
Beck Bode LLC's Alkermes position peaked at $738K in Q1 2024.
322 funds tracked by Wall St. Rank held Alkermes as of Q2 2024.

Based on Beck Bode LLC's 13F filing for Q2 2024, filed 12 Aug 2024.